Aimei Health Technology Co, LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Several First Trust entities have updated their beneficial ownership filings for Aimei Health Technology Co., Ltd., reporting significant holdings in the company's ordinary shares.
NASDAQ
W. R. Berkley Corporation and Berkley Insurance Company have filed a Schedule 13G, reporting 0% beneficial ownership of Aimei Health Technology Co., Ltd. ordinary shares.
NASDAQ
Mizuho Financial Group reports 0% beneficial ownership in Aimei Health Technology Co., Ltd. common shares in its latest Schedule 13G amendment.
NASDAQ
Karpus Management, Inc. reported a 1.28% beneficial ownership stake in Aimei Health Technology Co., Ltd. as of December 31, 2025.
NASDAQ
Wolverine Asset Management and its affiliates have filed an amended Schedule 13G, reporting zero beneficial ownership in Aimei Health Technology Co., Ltd.
NASDAQ
Mizuho Financial Group, Inc. has disclosed a 9.0% beneficial ownership stake in Aimei Health Technology Co., Ltd. through its subsidiaries.
NASDAQ
W. R. Berkley Corporation and its subsidiary Berkley Insurance Company have disclosed a 6.9% beneficial ownership stake in Aimei Health Technology Co., Ltd, totaling 425,361 ordinary shares.
NASDAQ
Mizuho Financial Group, Inc. has filed an amended Schedule 13G, revealing a 9% beneficial ownership stake in Aimei Health Technology Co., Ltd. as of March 31, 2025.
NASDAQ
W. R. Berkley Corporation and its subsidiary, Berkley Insurance Company, have reported a beneficial ownership of 5.6% in Aimei Health Technology Co., Ltd.'s Ordinary Shares.
NASDAQ
Karpus Management, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 17.64% in Aimei Health Technology Co., Ltd.
NASDAQ
SCHEDULE 13G/A: First Trust Entities Disclose Significant Passive Stakes in Aimei Health Technology Co., Ltd.
First Trust Merger Arbitrage Fund and affiliated entities have disclosed beneficial ownership exceeding 10% in Aimei Health Technology Co., Ltd.'s Ordinary Shares, held for passive investment purposes.
NASDAQ
SCHEDULE 13G: Glazer Capital and Paul J. Glazer Disclose 6.71% Stake in Aimei Health Technology Co Ltd
Investment firm Glazer Capital, LLC and its Managing Member Paul J. Glazer have disclosed a 6.71% beneficial ownership stake in Aimei Health Technology Co Ltd, holding 605,795 ordinary shares.
NASDAQ
Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 6.71% in Aimei Health Technology Co Ltd, totaling 605,795 ordinary shares as of December 31, 2024.
NASDAQ
SCHEDULE 13G/A: Wealthspring Capital LLC and Matthew Simpson Report Full Divestment of Aimei Health Technology Shares
Wealthspring Capital LLC and Matthew Simpson have reported a 0% beneficial ownership in Aimei Health Technology Co., LTD as of December 31, 2024, indicating a full divestment of their previously held stake.
NASDAQ
Mizuho Financial Group, Inc. has filed a Schedule 13G, revealing a 9.9% beneficial ownership stake in Aimei Health Technology Co., Ltd.'s common shares.
NASDAQ
Wolverine Asset Management LLC and its affiliated entities have filed an amended Schedule 13G, reporting a passive beneficial ownership of 7.25% in Aimei Health Technology Co., Ltd.'s Ordinary Shares as of December 31, 2024.